CompletedPhase 2NCT00362310

Treatment of Classical Non-HIV-Related Kaposi's Sarcoma With the Antiviral Drug Indinavir

Studying Kaposi sarcoma

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Istituto Superiore di Sanità
Principal Investigator: Barbara Ensoli, MD, PhD
National AIDS Center, Istituto Superiore di Sanità, Rome, Italy
Intervention: indinavir(drug)
Enrollment: 28 target
Eligibility: 18 years · All sexes
Timeline: 2003 – 2007

Study locations (9)

Centro di Riferimento Oncologico (CRO),, Aviano, Italy
Department of Internal Medicine, University of Cagliari, Cagliari, Italy
Dermatologic Clinic, Ospedale S. Anna, Ferrara, Italy
Ospedale Maggiore, Mangiagalli e Regina Elena, IRCCS,, Milan, Italy
Ospedale Civico Benfratelli, Palermo, Italy
Department of Dermatological/Venereal Diseases and Plastic Surgery, University "La Sapienza", Rome, Italy
Istituto Dermatologico S. Gallicano-IRCCS, Rome, Italy
Istituto Dermopatico dell'Immacolata-IRCCS (IDI), Rome, Italy
Dermatology Clinic, University of Sassari, Sassari, Italy

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00362310 on ClinicalTrials.gov

Other trials for Kaposi sarcoma

Additional recruiting or active studies for the same condition.

See all trials for Kaposi sarcoma →

← Back to all trials